# ClinicalTrials.gov record NCT01416649

> PeptideScanner retained ClinicalTrials.gov record NCT01416649 at 2026-07-30T19:14:02.187Z. Its registry update date was 2023-04-26, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct01416649-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-04-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01416649-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01416649-exenatide-v1.json
- Content SHA-256: `f00a208c248fec4b228d8290b945e44bd34174e0efd3f10585817bf1f9f79ded`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01416649 ([`ctg-observation-nct01416649-2023-04-26-b67672b6a977`](#source-ctg-observation-nct01416649-2023-04-26-b67672b6a977))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01416649 at 2026-07-30T19:14:02.187Z. Its registry update date was 2023-04-26, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01416649-2023-04-26-b67672b6a977`](#source-ctg-observation-nct01416649-2023-04-26-b67672b6a977))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01416649 at 2026-07-30T19:14:02.187Z. Its registry update date was 2023-04-26, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01416649-2023-04-26-b67672b6a977`](#source-ctg-observation-nct01416649-2023-04-26-b67672b6a977))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01416649-2023-04-26-b67672b6a977`](#source-ctg-observation-nct01416649-2023-04-26-b67672b6a977))

## Sources

<a id="source-ctg-observation-nct01416649-2023-04-26-b67672b6a977"></a>
- **ClinicalTrials.gov record NCT01416649 · retained source version 2023-04-26:b67672b6a9773a9de150d2acc81e121bfff3aecae7907c4ec7afda0d37c768d1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01416649) (`ctg-observation-nct01416649-2023-04-26-b67672b6a977`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01416649." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01416649-exenatide-v1.json SHA-256: f00a208c248fec4b228d8290b945e44bd34174e0efd3f10585817bf1f9f79ded.